Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on.
CONCLUSION: OPAT use has increased and is used to treat patients with comorbidities, who are older, and with a different case-mix than 1999. Safety has not been compromised but the risk of treatment failure has increased. A better understanding of the reasons for treatment failure would improve patient selection and management with OPAT.
PMID: 31465324 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
More News: Antibiotic Therapy | Ceftriaxone | Cellulitis | Computers | Databases & Libraries | General Medicine | IV Therapy | New Zealand Health | Nurses | Nursing | Palliative | Palliative Care | Rocephin | Statistics | Study | Urinary Tract Infections